Most cancer drugs today are more effective and accessible than ever—yet patients often face crushing costs because our healthcare system still values profit over patient benefit. What if the key to transforming cancer care affordability lies in rethinking insurance design, reforming PBMs, and empowering employers with transparent data? In this eye-opening episode of Value-Based Voices, host Jayson Slotnik, JD, MPH, Partner, Health Policy Strategies, Inc., and Member of the AVBCC Board of Directors, sits down with healthcare thought leader John O'Brien, PharmD, MPH, President and CEO of the National Pharmaceutical Council, and healthcare policy strategist Brian Reid, MS, Senior Fellow at Tufts-CEVR and author of the Cost Curve newsletter. They explore how recent policy shifts, advances in medicine, and innovative data tools could finally create a healthcare environment where high-value cancer treatments reach those who need them most—without unnecessary barriers or skyrocketing costs. Discover the revolutionary potential of value-based insurance design and how new approaches to drug pricing, formulary placement, and patient cost sharing could reshape the future of cancer care. You'll learn about the critical barriers—such as rebates, rebates-driven formulary decisions, and cost-sharing hurdles—and how a data-rich, employer-led movement could finally tip the balance toward affordability and access. We break down the crucial role of employers, PBMs, and policy reforms in enabling this shift, as well as the clinical, economic, and patient-centered benefits of prioritizing value. With insights from recent research, upcoming innovations in cancer medicine delivery, and a forward-looking view of industry trends, you'll understand why this is the moment to watch for change—and be part of it. Perfect for healthcare professionals, policymakers, advocates, and anyone impacted by cancer treatment costs—this episode offers a compelling look at the potential to dramatically improve how we deliver and pay for life-saving medicines. If you're ready for a future where affordability meets innovation, this conversation is essential listening. Resources & Links: - National Pharmaceutical Council - Health Affairs - Cost Curve Newsletter - Brian Reid's Website Connect: - Dr. John O'Brien - Brian Reid - Jayson Slotnik Contact Value-Based Voices - Follow AVBCC on LinkedIn - View our podcast lineup - Contact us at info@avbcc.org Thanks for listening!
